Who owns BIOLINE RX LIMITED SPONSORED ADR?
- Ticker: BLRX
- CUSIP Number: 09071m304
Tip: Access positions for across all investors
Analyze quarterly positions in Bioline Rx with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bioline Rx stock
Who bought or sold BIOLINE RX LIMITED SPONSORED ADR this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Rhumbline Advisers | 2.4k | $5.4k | -30% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 1.8k | $4.1k | 20% | Mar 2026 |
|
| Wells Fargo & Company | 1.8k | $4.0k | 0% | Mar 2026 |
|
| Citigroup | 1.7k | $4.0k | 100% | Mar 2026 |
|
| UBS Group | 529.00 | $1.2k | -73% | Mar 2026 |
|
| Nemes Rush Group | 250.00 | $575.000000 | 0% | Mar 2026 |
|
| Goss Wealth Management | 107.00 | $246.998800 | 0% | Mar 2026 |
|
| Morgan Stanley | 100.00 | $230.000000 | 0% | Mar 2026 |
|
| Advisor Group Holdings | 26.00 | $71.000800 | 2500% | Dec 2025 |
|
| Rockefeller Capital Management | 12.00 | $27.999600 | 0% | Mar 2026 |
|
| Danske Bank A/s | 2.00 | $5.000000 | 0% | Mar 2026 |
|
| Banque Cantonale Vaudoise | 1.00 | $0 | 0% | Mar 2026 |
|
Who sold out of Bioline Rx?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2025 | 60k | $172k |
| Susquehanna International | Sep 2025 | 20k | $76k |
| Simplex Trading | Sep 2025 | 105.00 | $0 |
| Tower Research Capital | Sep 2025 | 39.00 | $146.998800 |